Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-07-07 00:00:00 ET · period of report 2022-07-06 · accession 0001209191-22-041440 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-07 | 2022-07-06 | FATE | Valamehr Bahram | Chief R, D Off | S - Sale+OE | $30.07 | -7,842 | 179.8K | -4% | -$235.8K |
| DM | 2022-07-07 | 2022-07-06 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $3.27 | +7,842 | 187.7K | +4% | +$25.6K |
| DM | 2022-07-07 | 2022-07-06 | FATE | Valamehr Bahram | Chief R, D Off | M - OptEx | $3.27 | -7,842 | 8,704 | -47% | -$25.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-06 | S | D | 7,842 | $30.07 | 179,834 | D | — | — | (F2) Represents the weighted average sale price of the shares sold ranging from $30.00 to $30.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range set forth in footnote 2. |
| 2 | Common | Common Stock | 2022-07-06 | M | A | 2,000 | $4.84 | 181,834 | D | — | — | |
| 3 | Common | Common Stock | 2022-07-06 | M | A | 5,842 | $2.73 | 187,676 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-07-06 | M | D | 5,842 | $2.73 | 30,314 | D | $2.73 · — to 2027-01-04 | 5,842 Common Stock | (F3) This option is fully vested. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-07-06 | M | D | 2,000 | $4.84 | 8,704 | D | $4.84 · — to 2025-01-05 | 2,000 Common Stock | (F3) This option is fully vested. |